These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2359187)

  • 1. Absence of effect of allopurinol on oxalate excretion by stone patients on random and controlled diets.
    Urivetzky M; Braverman S; Motola JA; Smith AD
    J Urol; 1990 Jul; 144(1):97-8. PubMed ID: 2359187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of allopurinol on urinary oxalate excretion in stone formers.
    Scott R; Paterson PJ; Mathieson A; Smith M
    Br J Urol; 1978 Dec; 50(7):455-8. PubMed ID: 753494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allopurinol in the recurrence prevention of calcium oxalate lithiasis.
    Brien G; Bick C
    Eur Urol; 1977; 3(1):35-6. PubMed ID: 837952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary oxalate levels are not affected by dietary purine intake or allopurinol.
    Morris GS; Simmonds HA; Toseland PA; Van Acker KJ; Davies PM; Stuchbury JH
    Br J Urol; 1987 Oct; 60(4):292-300. PubMed ID: 3690198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of animal and vegetable protein intake on oxalate excretion in idiopathic calcium stone disease.
    Marangella M; Bianco O; Martini C; Petrarulo M; Vitale C; Linari F
    Br J Urol; 1989 Apr; 63(4):348-51. PubMed ID: 2713614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does hyperuricosuria play a role in calcium oxalate lithiasis?
    Ettinger B
    J Urol; 1989 Mar; 141(3 Pt 2):738-41. PubMed ID: 2645432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in urinary oxalate values by allopurinol.
    Scott R; Paterson PJ; Smith M; Mathieson A
    Urology; 1978 Aug; 12(2):212-4. PubMed ID: 695155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine composition in patients with renal stone disease during treatment with allopurinol.
    Tiselius HG; Larsson L
    Scand J Urol Nephrol; 1980; 14(1):65-71. PubMed ID: 7375845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seasonal variation in urinary excretion of calcium, oxalate, magnesium and phosphate on free and standard mineral diet in men with urolithiasis.
    Juuti M; Heinonen OP; Alhava EM
    Scand J Urol Nephrol; 1981; 15(2):137-41. PubMed ID: 7330607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of calcium oxalate crystal growth in urine during treatment with allopurinol.
    Tiselius HG
    Br J Urol; 1980 Jun; 52(3):189-92. PubMed ID: 7426978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical studies of the recurrence of urolithiasis (3). Influence of sodium intake on urinary excretion of calcium, uric acid, oxalate, phosphate and magnesium].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1537-41. PubMed ID: 3213789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allopurinol and thiazide effects on new urinary stone formed after discontinued therapy in patients with urinary stones.
    Kohri K; Kodama M; Katayama Y; Ishikawa Y; Takada M; Kataoka K; Katoh Y; Iguchi M; Kurita T
    Urology; 1990 Oct; 36(4):309-14. PubMed ID: 2219608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dietary control for out-patients in urinary stone clinic].
    Kato T; Yanagawa M; Hioki T; Sakurai M; Yamakawa K; Araki T; Yamamoto I; Arima K; Tochigi H; Kawamura J
    Hinyokika Kiyo; 1993 Jul; 39(7):593-8. PubMed ID: 8362676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current status of prevention and therapy of urinary calculi and peroral chemo-litholysis with special attention to the relationship of increased excretion of uric acid in oxalate lithiasis].
    Leskovar P
    Z Urol Nephrol; 1980 Mar; 73(3):229-39. PubMed ID: 7434987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary supersaturation with calcium oxalate before and during orthophosphate therapy.
    Burdette DC; Thomas WC; Finlayson B
    J Urol; 1976 Apr; 115(4):418-22. PubMed ID: 1263318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatment of uric acid calculi.
    Preminger GM
    Urol Clin North Am; 1987 May; 14(2):335-8. PubMed ID: 3576854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical results of allopurinol treatment in prevention of calcium oxalate stone formation.
    Tiselius HG; Larsson L; Hellgren E
    J Urol; 1986 Jul; 136(1):50-3. PubMed ID: 3712614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
    Penniston KL; Nakada SY
    Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical studies on bilharzial and nonbilharzial hyperoxaluria: effect of pyridoxine and allopurinol treatment.
    el-Habet AE; el-Sewedy SM; el-Sharaky A; Gaafar NK; Abdel-Rafee A; Hamoud F
    Biochem Med Metab Biol; 1987 Aug; 38(1):1-8. PubMed ID: 3663392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.